Tenet Healthcare director Roy Blunt sells $157,608 in company stock
On August 5, 2026, Roy Blunt, a director at Tenet Healthcare Corp, sold 600 shares of the company's common stock. The total value of the transaction was $157,608, with each share sold for a price between $262.52 and $262.70 per share. This sale reduced Blunt's direct ownership of Tenet Healthcare common stock to 4,589 shares. Despite this sale, the stock price of Tenet Healthcare is trading near its 52-week high of $270.57, having delivered a 56% return over the past year.
InvestingPro analysis indicates that the stock remains undervalued, trading at a P/E ratio of 10.38. Tenet Healthcare recently reported impressive second-quarter 2026 results, surpassing Wall Street's expectations with adjusted earnings of $6.12 per share and revenue of $5.63 billion. Following these results, the company has raised its full-year outlook.
Several analysts have responded positively to these developments, with price targets ranging from $270 to $308.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
